Lung Cancer Vaccine
Lung Cancer
PreclinicalActive
Key Facts
About Seqker Biosciences
Seqker builds AI‑driven neoantigen vaccines and genomic diagnostics to deliver personalized oncology treatments.
View full company profileTherapeutic Areas
Other Lung Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| OncoStrong™ | Lamark Biotech | Preclinical |
| 15dPMJ2 | Claradele Pharmaceuticals | Research |
| SUPLEXA | Alloplex Biotherapeutics | Phase 1 |
| Oncology Digital Biomarkers | Imvaria | Development |
| Aerosolized Platinum Nanoparticles | HylaPharm | Pre-clinical |
| ENV105 | Kairos Pharma | Phase 1 |
| AI for Lung Cancer | Invenio Imaging | Research |
| Liposome Program | NanoTech Pharma | Preclinical/Phase 1/2 |
| Dendritic Cell Vaccine | MegaNano BioTech | Pre-clinical |
| AI Biomarkers for Lung Cancer | BioAI Health | Unknown |
| PRDM2 Target | ARIZ Precision Medicine | Preclinical |
| ZEN-3694 | Zenith Epigenetics | Proof-of-Concept |